I hear you on these - I'd be more interested in how you see the offramp, because in my experience the challenge isn't the early stage innovation, it is the stages of validation and early commercialization where financial outcomes aren't clear and capital is able to get better returns elsewhere. Without thinking though those two stages I fear this program will fail as previous ones did.
> license that IP via a standard, non-exclusive license to any American entity
I would suggest a standardised reference license with optional clauses for most likely pathways (open-source, exclusive use, JV, etc). Not intended to be definitive (open to negotiation) but give default settings ...
Ben - this is well said and I would love to further pick your brain. I had similar response to the RFI and firmly believe that there is a real opportunity to unlock innovation and industrialization within NSF via the call and subsequent focus areas.
I hear you on these - I'd be more interested in how you see the offramp, because in my experience the challenge isn't the early stage innovation, it is the stages of validation and early commercialization where financial outcomes aren't clear and capital is able to get better returns elsewhere. Without thinking though those two stages I fear this program will fail as previous ones did.
> license that IP via a standard, non-exclusive license to any American entity
I would suggest a standardised reference license with optional clauses for most likely pathways (open-source, exclusive use, JV, etc). Not intended to be definitive (open to negotiation) but give default settings ...
Ben - this is well said and I would love to further pick your brain. I had similar response to the RFI and firmly believe that there is a real opportunity to unlock innovation and industrialization within NSF via the call and subsequent focus areas.